Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Oncology · Clear Cell Renal Cell Carcinoma

Surgical Options for Localized ccRCC

At a Glance

For localized clear cell renal cell carcinoma (ccRCC), partial nephrectomy is the preferred treatment for smaller tumors to remove the cancer while preserving healthy kidney tissue. Saving this tissue lowers your long-term risk of chronic kidney disease and cardiovascular problems.

When treating localized clear cell renal cell carcinoma (ccRCC), the primary goal of surgery is to remove the cancer while preserving as much healthy kidney tissue as possible. This approach is known as nephron-sparing surgery. Modern surgical techniques have shifted toward protecting your long-term kidney health, as having two functioning kidneys (or as much of them as possible) reduces the risk of chronic kidney disease and heart-related issues later in life [1][2].

Partial vs. Radical Nephrectomy

There are two main types of surgery for localized kidney cancer:

  • Partial Nephrectomy (PN): Only the tumor and a small “rim” of healthy tissue around it are removed. This is the preferred “standard of care” for smaller tumors (T1 tumors, which are 7 centimeters or less) [1][2].
  • Radical Nephrectomy (RN): The entire kidney, and sometimes the surrounding fat and adrenal gland, are removed. This is usually reserved for very large tumors (T2 or larger), tumors that are deeply embedded in the center of the kidney, or cases where a partial nephrectomy is too risky [3][4].

Decoding Tumor Complexity: R.E.N.A.L. and PADUA

Surgeons don’t just guess if a partial nephrectomy is possible; they use specialized scoring systems to measure the tumor’s “difficulty level” based on your imaging [5].

  • R.E.N.A.L. Nephrometry Score: This is the most common system. It scores the tumor based on its Radius (size), whether it is Exophytic (on the surface) or Endophytic (deep inside), its Nearness to the kidney’s drainage system, whether it is Anterior (front) or posterior (back), and its Location relative to the top or bottom of the kidney [5][6].
  • PADUA Score: A similar system that also looks at the tumor’s relationship to the kidney’s center and blood vessels [7].

A low score (4–6) suggests a straightforward partial nephrectomy is likely, while a high score (10+) indicates a complex tumor that might require a radical nephrectomy to ensure all the cancer is removed [8][9].

Surgical Approaches: Robotic, Laparoscopic, and Open

How the surgeon accesses the kidney also matters for your recovery:

  • Robot-Assisted Surgery: This is now the most common approach for partial nephrectomy [2]. The surgeon uses a robotic system to perform the surgery with tiny instruments and 3D vision. It often results in less blood loss. Robotic surgery usually involves a hospital stay of 1 to 3 days and a few weeks of recovery at home [10][11].
  • Laparoscopic Surgery: Similar to robotic surgery, this uses small incisions and a camera but without the robotic “hands.” It is often used for radical nephrectomies [12].
  • Open Surgery: This involves a traditional large incision. While less common today, it is still the safest and most effective option for extremely large or complex tumors that cannot be safely managed with a camera or robot [13]. Open surgery may require 3 to 5 days in the hospital and 4 to 6 weeks for full recovery.

Thermal Ablation for Small Tumors

For older patients, or those who are not good candidates for surgery due to other health conditions, thermal ablation (freezing or heating the tumor) is a minimally invasive alternative for small tumors (T1a) [14].

The Long-Term Benefit: Nephron-Sparing

The reason doctors push for partial nephrectomy whenever possible is the long-term benefit of “nephron-sparing.” Nephrons are the tiny filtering units of the kidney. Preserving them helps prevent Chronic Kidney Disease (CKD) [15][16]. Patients who keep more of their kidney tissue have a lower risk of developing high blood pressure and cardiovascular disease in the years following surgery [15][1]. If you already have some kidney issues, or have conditions like diabetes or hypertension, sparing your nephrons becomes even more critical [17].

Common questions in this guide

What is the difference between a partial and radical nephrectomy?
A partial nephrectomy removes only the tumor and a small rim of healthy tissue around it, preserving the rest of your kidney. A radical nephrectomy removes the entire kidney and is usually reserved for larger, deeper, or more complex tumors.
What is a R.E.N.A.L. nephrometry score?
A R.E.N.A.L. score is a system surgeons use to measure the complexity of your kidney tumor based on imaging scans. It evaluates the tumor's size, depth, and location to help determine if a partial nephrectomy can be safely performed.
Why do doctors prefer nephron-sparing surgery for kidney cancer?
Nephron-sparing surgery, such as a partial nephrectomy, saves as much healthy kidney tissue as possible. Keeping more of your functioning kidney helps prevent chronic kidney disease and lowers your long-term risk of developing high blood pressure and heart problems.
Can localized ccRCC be treated without surgery?
For older patients or those with health conditions that make surgery too risky, thermal ablation may be an alternative for small tumors. This minimally invasive procedure destroys the cancer cells by either freezing or heating the tumor.
How does robotic kidney surgery compare to open surgery?
Robot-assisted surgery uses a robotic system, small incisions, and 3D vision, which often results in less blood loss and a hospital stay of just 1 to 3 days. Open surgery requires a larger incision and a longer recovery, but it is sometimes necessary for extremely large or complex tumors.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my scans, what is my R.E.N.A.L. or PADUA nephrometry score? What does it say about the complexity of my tumor?
  2. 2.Am I a candidate for a partial nephrectomy (nephron-sparing surgery), and if not, what are the specific reasons why?
  3. 3.How will my kidney function be affected long-term if we choose a radical nephrectomy versus a partial nephrectomy?
  4. 4.What is your experience with robotic-assisted surgery for tumors of this size and location?
  5. 5.What are the risks of complications, such as bleeding or urine leaks, with a partial nephrectomy in my specific case?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Benefit of nephron sparing surgery translates into lower cancer specific mortality in patients with localized renal cell carcinoma.

    Mistretta FA, Mazzone E, Knipper S, Karakiewicz PI

    Annals of translational medicine 2018; (6(Suppl 2)):S104 doi:10.21037/atm.2018.11.37.

    PMID: 30740425
  2. 2

    Robot-assisted partial nephrectomy for renal cell carcinoma: A narrative review of different clinical scenarios.

    Grosso AA, Salamone V, Di Maida F, et al.

    Asian journal of urology 2025; (12(2)):210-216 doi:10.1016/j.ajur.2024.09.010.

    PMID: 40458586
  3. 3

    Surgical Strategies in Renal Cancer: A Meta-analysis of Partial vs. Radical Nephrectomy Outcomes Across Tumor Stages.

    Al-Qudimat AR, Altahtamouni SB, Elaarag M, et al.

    Qatar medical journal 2025; (2025(2)):54 doi:10.5339/qmj.2025.54.

    PMID: 40556844
  4. 4

    Patients with high nuclear grade pT1-ccRCC are more suitable for radical nephrectomy than partial nephrectomy: a multicenter retrospective study using propensity score.

    Xu H, Xing Z, Ai K, et al.

    World journal of surgical oncology 2024; (22(1)):24 doi:10.1186/s12957-024-03302-y.

    PMID: 38254091
  5. 5

    Parallel comparison of R.E.N.A.L., PADUA, and C-index scoring systems in predicting outcomes after partial nephrectomy: A systematic review and meta-analysis.

    Hu C, Sun J, Zhang Z, et al.

    Cancer medicine 2021; (10(15)):5062-5077 doi:10.1002/cam4.4047.

    PMID: 34258874
  6. 6

    Best predictive single nephrometry score component to correlate with achievement of trifecta outcome in laparoscopic and robotic surgery.

    Suppanuntaroek S, Garcia K, Combates C, et al.

    BMC urology 2024; (24(1)):134 doi:10.1186/s12894-024-01518-4.

    PMID: 38943111
  7. 7

    A "3S+f" Nephrometry Score System to Predict the Clinical Outcomes of Laparoscopic Nephron-Sparing Surgery.

    Zhang S, Qin Z, Bi H, et al.

    Frontiers in oncology 2022; (12()):922082 doi:10.3389/fonc.2022.922082.

    PMID: 35912177
  8. 8

    RENAL Nephrometry Scores and Perioperative Outcomes in Open Partial Nephrectomy.

    Nusrat NB, Kundi S, Rehman AU, et al.

    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2024; (34(12)):1524-1529 doi:10.29271/jcpsp.2024.12.1524.

    PMID: 39648390
  9. 9

    Comparison of perioperative outcomes of robotic vs. laparoscopic partial nephrectomy for renal tumors with a RENAL nephrometry score ≥7: A meta-analysis.

    Jiang YL, Yu DD, Xu Y, et al.

    Frontiers in surgery 2023; (10()):1138974 doi:10.3389/fsurg.2023.1138974.

    PMID: 37009605
  10. 10

    Impact of obesity on peri-operative outcomes at robotic-assisted, laparoscopic and open partial nephrectomy using national inpatient sample data.

    Faheem MSB, Shahabi M, Ayub A, et al.

    Journal of robotic surgery 2026; (20(1)):272 doi:10.1007/s11701-026-03178-y.

    PMID: 41714446
  11. 11

    Comparison of therapeutic effects between transabdominal robot-assisted partial nephrectomy and laparoscopic partial nephrectomy.

    Zuo C, Gao Z, Gu Y

    The Journal of international medical research 2025; (53(10)):3000605251390064 doi:10.1177/03000605251390064.

    PMID: 41161859
  12. 12

    Comparative analysis of Robotic-Assisted, Laparoscopic, and open radical nephrectomy: Utilization, Costs, and clinical outcomes.

    Huang DY, Lallas CD, Davis RM, et al.

    Journal of robotic surgery 2025; (20(1)):41 doi:10.1007/s11701-025-02995-x.

    PMID: 41276716
  13. 13

    Comparing robotic and open partial nephrectomy under the prism of surgical precision: a meta-analysis of the average blood loss rate as a novel variable.

    Artsitas S, Artsitas D, Koronaki I, et al.

    Journal of robotic surgery 2024; (18(1)):313 doi:10.1007/s11701-024-02060-z.

    PMID: 39112829
  14. 14

    Diagnostic accuracy of percutaneous renal mass biopsy in patients undergoing robot-assisted partial nephrectomy for localized renal cell carcinoma.

    Timane JP, Petersson RD, Jepsen RK, Thomsen FF

    Urologic oncology 2025; (43(12)):708.e1-708.e6 doi:10.1016/j.urolonc.2025.09.002.

    PMID: 41016893
  15. 15

    Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis.

    Ochoa-Arvizo M, García-Campa M, Santos-Santillana KM, et al.

    Urologic oncology 2023; (41(3)):113-124 doi:10.1016/j.urolonc.2022.11.024.

    PMID: 36642639
  16. 16

    Prediction of significant estimated glomerular filtration rate decline after renal unit removal to aid in the clinical choice between radical and partial nephrectomy in patients with a renal mass and normal renal function.

    McIntosh AG, Parker DC, Egleston BL, et al.

    BJU international 2019; (124(6)):999-1005 doi:10.1111/bju.14839.

    PMID: 31145523
  17. 17

    Should partial nephrectomy be considered "elective" in patients with stage 2 chronic kidney disease? A comparative analysis of functional and survival outcomes after radical and partial nephrectomy.

    Hamilton ZA, Capitanio U, Lane BR, et al.

    World journal of urology 2019; (37(11)):2429-2437 doi:10.1007/s00345-019-02650-9.

    PMID: 30710156

This page provides educational information about surgical options for localized ccRCC. It does not replace professional medical advice from your urologist or oncologist regarding your specific treatment plan.

Get notified when new evidence is published on Clear cell renal carcinoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.